BiotechTubeBiotechTube
Home/Chimerna Therapeutics/Brian Pickering, Ph.D.
BP

Brian Pickering, Ph.D.

Chief Executive Officer

Chimerna Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesMetabolic DiseasesOncologyCardiovascularAutoimmune

Chimerna Therapeutics Pipeline

DrugIndicationPhase
Tornado Platform - RNA AptamersAlzheimer's Disease, Parkinson's Disease, ALS (Lou Gehrig's Disease), Non-alcoholic steatohepatitis (NASH)Pre-clinical
Tornado-based microRNA Sponge LibrariesMicroRNA-related diseases (e.g., Cancer, Heart Disease, Autoimmune, Neurodevelopmental)Platform/Tool Development
Target RNA‐directed miRNA Degradation (TDMD) PlatformMicroRNA-related diseases (Target Discovery)Platform/Tool Development
Recombinant Protein Yield Enhancement TechnologyBiomanufacturing / Production of biologic drugsPlatform/Tool Development

Leadership Team at Chimerna Therapeutics

JL
Jacob Litke, Ph.D.
Chief Scientific Officer, President
SJ
Samie Jaffrey, M.D., Ph.D.
Scientific Advisor, Greenburg-Starr Professor at Weill Cornell Medicine
View full Chimerna Therapeutics profile